October 21,2016

Johnson & Johnson Announces FDA Approval of Chewable Mebendazole

In a press release on October 19, 2016, Janssen Pharmaceutical Companies of Johnson & Johnson announced US FDA approval of chewable Mebendazole for treatment of roundworm and whipworm infections in children and adults. Read the press release here. Johnson & Johnson, along with the Task Force for Global Health, is a founding partner of CWW. 

Share This Article